Mediqas Pharma

Ophthalmic pharmaceutical products and related services in the healthcare sector.

About Mediqas Pharma

Mediqas Pharma is a Healthcare company. Ophthalmic pharmaceutical products and related services in the healthcare sector. The company has 40 employees. Its Indian entity Mediqas Pharma Private Limited reported revenue of β‚Ή1.44 Cr. Mediqas Pharma offers products and services including Ophthalmic Drugs and Visual Aids. Its focus areas include Medical Devices, Visual Aids, Supportive Equipment and Pharmaceuticals.

Company details

Mediqas Pharma is identified as a leading entity in the ophthalmic pharmaceutical field, where products such as eye care medications and visual aids are developed and distributed. Strict regulatory measures are applied to ensure safety and honesty in operations, with adaptations made for local audiences and payment methods. Tools for responsible usage and self-control are provided, making services accessible via digital platforms for convenience. Emphasis is placed on innovation and compliance, allowing products to be offered securely and efficiently to users.

  • Employees 40
  • Sectors
    Healthcare
  • Legal Name Mediqas Pharma Pvt. Ltd
  • Date of Incorporation 12 Feb, 2020
  • Jurisdiction Ghaziabad, Uttar Pradesh, India
Key Metrics
  • Indian entity revenue
    ₹1.44 Cr

    FY 2023 · +89% YoY

  • Indian entity net profit
    ₹3.6 Lakh

    FY 2023 · 3% margin

  • Indian entity EBITDA
    ₹20.5 Lakh

    FY 2023 · 14% margin

  • Employee Count
    40

Products & Services of Mediqas Pharma

Mediqas Pharma offers a comprehensive portfolio of products and services, including Ophthalmic Drugs and Visual Aids.

Ophthalmic Drugs
Pharmaceuticals

Development and distribution of eye care medications are carried out for various health applications

Visual Aids
Medical Devices

Provision of supportive equipment for visual impairments is made available to assist users

Board of directors of Mediqas Pharma Private Limited (Mediqas Pharma)

Mediqas Pharma Private Limited is the primary company behind Mediqas Pharma. The board of Mediqas Pharma Private Limited currently have 2 directors; the longest-serving is Rinki Jha, appointed in 2020. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Rinki Jha
DIN 06448155
Director12 Feb 20206 yrs 8 moMediqas Pharma Private Limited
Chandra Nand Jha
DIN 02672457
Managing Director13 Apr 20206 yrs 6 moMediqas Pharma Private Limited

Financials of Mediqas Pharma

Figures of Mediqas Pharma Private Limited, the primary company behind Mediqas Pharma, for FY 2023. Revenue was ₹1.44 Cr (+89% year on year). Net profit was ₹3.6 Lakh (3% margin). EBITDA was ₹20.5 Lakh (14% margin).

  • ₹1.44 CrRevenue · FY 2023 · +89% YoY
  • ₹3.6 LakhNet profit · 3% margin
  • ₹20.5 LakhEBITDA · 14% margin
  • ₹10 LakhPaid-up capital
  • 40Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Mediqas Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Mediqas Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mediqas Pharma

Mediqas Pharma has 40 employees.

The primary company behind Mediqas Pharma, Mediqas Pharma Private Limited, reported revenue of β‚Ή1.44 Cr for FY 2023, up 89% year on year.

Mediqas Pharma is identified as a leading entity in the ophthalmic pharmaceutical field, where products such as eye care medications and visual aids are developed and distributed. Strict regulatory measures are applied to ensure safety and honesty in operations, with adaptations made for local audiences and payment methods. Tools for responsible usage and self-control are provided, making services accessible via digital platforms for convenience. Emphasis is placed on innovation and compliance, allowing products to be offered securely and efficiently to users.

Mediqas Pharma offers Ophthalmic Drugs and Visual Aids.

Mediqas Pharma operates through Mediqas Pharma Private Limited.

The legal entities of Mediqas Pharma currently have 2 directors, including Rinki Jha, Chandra Nand Jha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available